medroxyprogesterone acetate has been researched along with Koch's Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badal-Faesen, S; Cohn, SE; Coughlin, K; Cramer, Y; Dooley, K; Firnhaber, C; Godfrey, C; Kendall, MA; Mawlana, S; Mcilleron, H; Mngqibisa, R; Omoz-Oarhe, A; Roa, J; Robinson, J; Rosenkranz, SL; Samaneka, W; Schnabel, D; Wu, XS | 1 |
| Cohn, SE; Denti, P; Dooley, KE; Firnhaber, C; Francis, J; Godfrey, C; Kendall, MA; McIlleron, H; Mngqibisa, R; Wu, X | 1 |
| Angira, F; Badal-Faesen, S; Baker, P; Cohn, SE; Denti, P; Francis, J; Haas, DW; Kendall, MA; Mawlana, S; McIlleron, H; Mngqibisa, R; Omoz-Oarhe, A; Robinson, JA; Samaneka, WP | 1 |
| Allie, N; Du Plessis, N; Jacobs, M; Kidd, M; Kleynhans, L; Ronacher, K; van Helden, PD; Walzl, G | 1 |
1 trial(s) available for medroxyprogesterone acetate and Koch's Disease
| Article | Year |
|---|---|
Pharmacogenetics of interaction between depot medroxyprogesterone acetate and efavirenz, rifampicin, and isoniazid during treatment of HIV and tuberculosis.
Topics: Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Drug Interactions; Female; HIV Infections; Humans; Isoniazid; Medroxyprogesterone Acetate; Pharmacogenetics; Rifampin; Tuberculosis | 2022 |
3 other study(ies) available for medroxyprogesterone acetate and Koch's Disease
| Article | Year |
|---|---|
Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate in African Women Receiving Treatment for Human Immunodeficiency Virus and Tuberculosis: Potential Concern for Standard Dosing Frequency.
Topics: Adult; Africa; Contraceptive Agents, Female; Delayed-Action Preparations; Female; HIV; HIV Infections; Humans; Medroxyprogesterone Acetate; Pregnancy; Reference Standards; Tuberculosis | 2020 |
A Semimechanistic Pharmacokinetic Model for Depot Medroxyprogesterone Acetate and Drug-Drug Interactions With Antiretroviral and Antituberculosis Treatment.
Topics: Alkynes; Anti-Retroviral Agents; Antitubercular Agents; Benzoxazines; Contraceptive Agents, Hormonal; Contraceptive Effectiveness; Cyclopropanes; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Delayed-Action Preparations; Drug Administration Schedule; Drug Combinations; Drug Interactions; Female; HIV Infections; Humans; Isoniazid; Lopinavir; Medroxyprogesterone Acetate; Nelfinavir; Rifampin; Ritonavir; Tuberculosis | 2021 |
The contraceptive depot medroxyprogesterone acetate impairs mycobacterial control and inhibits cytokine secretion in mice infected with Mycobacterium tuberculosis.
Topics: Animals; Contraceptive Agents; Cytokines; Disease Models, Animal; Female; Immunologic Factors; Immunosuppression Therapy; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mycobacterium tuberculosis; Tuberculosis | 2013 |